Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
Clinical trial NCT06364150 · UNKNOWN
Trial details
- NCT number
- NCT06364150
- Sponsor
- Seoul National Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2025-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.